Cytotoxic CD8+ T cells in myeloma are in a state of telomere-independent senescence rather than an exhausted or anergic state: Implication for immune checkpoint blockade
Suen, H, Joshua, D, Brown, R, Yang, S, Ho, P.J, Gibson, J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Digital PCR for MRD detection of myeloma
McAuliffe, S, Joshua, D, Brown, R, Catalano, A, Ho, P.J, Nassif, N, Woodland, N, Hart, D, Weatherburn, C, Yang, S, Suen, H, Paul, C, Gibson, J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Real world management of multiple myeloma: initial results from the Australia and New Zealand Myeloma and Related Diseases Registry
Moore, E, Bergin, K, McQuilten, Z, Wood, E, Augustson, B, Blacklock, H, Ho, P.J, Horvath, N, King, T, McNeil, J, Mollee, P, Quach, H, Reid, C, Rosengarten, B, Walker, P, Spencer, A
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade
Suen, H, Brown, R, Yang, S, Weatherburn, C, Ho, P J, Woodland, N, Nassif, N, Barbaro, P, Bryant, C, Hart, D, Gibson, J, Joshua, D
Published in Leukemia (01.08.2016)
Published in Leukemia (01.08.2016)
Get full text
Journal Article
Characterising complex rearrangements with long-read sequencing in thalassaemia
French, H.J., Anderson, S., Deveson, I.W., Stevanovski, I., Nelson, A., Matthews, S., Gou, M., Cheong, P.L., Trent, R.J., Ho, P.J.
Published in Pathology (01.03.2022)
Published in Pathology (01.03.2022)
Get full text
Journal Article
31P Association between breast cancer protein truncating variants and febrile neutropenia breast cancer patients treated with taxane or anthracycline chemotherapy in Singapore
Ong, S.S., Ho, P.J., Khng, A.J., Lim, G.H., Lim, S.H., Ow, S.G.W., Pang, J.S., Tee Tan, B. Kiat, Tan, E.Y., Tan, S.M., Kiak Mien Tan, V., Wong, F.Y., Li, J., Hartman, M.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma
Brown, R, Yang, S, Weatherburn, C, Gibson, J, Ho, P J, Suen, H, Hart, D, Joshua, D
Published in Leukemia (01.02.2015)
Published in Leukemia (01.02.2015)
Get full text
Journal Article
ELARA: A PHASE 2 TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN ADULT PATIENTS WITH REFRACTORY/RELAPSED FOLLICULAR LYMPHOMA
Dickinson, M., Popplewell, L., Kolstad, A., Ho, P.J., Teshima, T., Dreyling, M., Schuster, S., Thieblemont, C., Ghosh, M., Riedell, P., Yateman, N., Lehnhoff, K., Lawniczek, T., Pacaud, L., Fowler, N.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
PS1387 CARFILZOMIB IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): FRAILTY SUBGROUP ANALYSIS FROM PHASE 3 ASPIRE AND ENDEAVOR
Facon, T., Niesvizky, R., Weisel, K., Bringhen, S., Ho, P.J., Obreja, M., Yang, Z., Klippel, Z., Blaedel, J., Mezzi, K., Siegel, D.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
S141 CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION‐DEPENDENT β‐THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB‐204) STUDY
Walters, M.C., Kwiatkowski, J.L., Rasko, J.E.J., Hongeng, S., Schiller, G.J., Anurathapan, U., Cavazzana, M., Ho, P.J., Schmidt, M., Kletzel, M., Leboulch, P., Vichinsky, E., Deary, B., Chen, Y., Petrusich, A., Thompson, A.A.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL‐TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS
Bachanova, V., Westin, J., Tam, C., Borchmann, P., Jaeger, U., McGuirk, J., Holte, H., Waller, E., Jaglowski, S., Bishop, M., Andreadis, C., Foley, S.R., Fleury, I., Teshima, T., Mielke, S., Salles, G., Ho, P.J., Izutsu, K., Maziarz, R., Van Besien, K., Kersten, M.J., Wagner‐Johnston, N., Kato, K., Corradini, P., Han, X., Agoulnik, S., Chu, J., Eldjerou, L., Pacaud, L., Schuster, S.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL
Jaeger, U., Tam, C., Borchmann, P., McGuirk, J., Holte, H., Waller, E., Jaglowski, S., Andreadis, C., Foley, S.R., Fleury, I., Westin, J., Teshima, T., Mielke, S., Salles, G., Ho, P.J., Izutsu, K., Schuster, S., Bachanova, V., Maziarz, R., Van Besien, K., Kersten, M.J., Wagner‐Johnston, N., Kato, K., Corradini, P., Tiwari, R., Forcina, A., Pacaud, L., Bishop, M.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
PF591 EFFICACY AND SAFETY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (D‐RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED SUBGROUP ANALYSIS OF POLLUX BASED ON CYTOGENETIC RISK
Dimopoulos, M.A., San‐Miguel, J., White, D., Benboubker, L., Cook, G., Leiba, M., Morton, J., Ho, P.J., Kim, K., Takezako, N., Moreau, P., Sutherland, H.J., Magen, H., Iida, S., Kim, J.S., Prince, H.M., Cochrane, T., Oriol, A., Bahlis, N.J., Chari, A., O’Rourke, L., Trivedi, S., Casneuf, T., Chiu, C., Soong, D., Ukropec, J., Qi, M., Avet‐Loiseau, H., Usmani, S.Z., Kaufman, J.L.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19‐TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)—AN INTERIM ANALYSIS
Schuster, S.J., Bishop, M.R., Tam, C., Waller, E.K., Borchmann, P., Mcguirk, J., Jäger, U., Jaglowski, S., Andreadis, C., Westin, J., Fleury, I., Bachanova, V., Foley, S.R., Ho, P.J., Mielke, S., Holte, H., Anak, O., Pacaud, L., Awasthi, R., Tai, F., Salles, G., Maziarz, R.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Evolving transplant options for multiple myeloma: Autologous and nonmyeloablative allogenic
Get full text
Journal Article
Conference Proceeding